Tag: inflammatory bowel diseases (IBD)

covid-19-SARS-CoV-2-Virus-v1_650x450
March 30, 2020/COVID-19

COVID-19: Implications for Managing Inflammatory Bowel Disease

Don’t stop anti-TNFs, ustekinumab or vedolizumab

19-DDI-6059-IBD-CQD

A New Era of IBD Care

Integrating novel treatment with pioneering research

19-DDI-3891_CQD_650x450_1
August 15, 2019/Digestive/Research

Gastrointestinal Research Roundup: Our Latest Findings in IBD, Barrett’s Esophagus

A quick review of several advances in risk assessment and treatment

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-DDI-161-Ileal-Pouch-Feat
June 5, 2019/Digestive/Surgery

Timing of Post-IPAA Complications Predicts Long-Term Outcomes

Conditional survival study finds pouch survival improves over time

Nonalcoholic cirrhosis
May 18, 2019/Digestive/Research

Studies Reveal Heightened Liver Disease Rates in IBD Patients

Immune-mediated factors may be involved

18-DDI-339-Regueiro-CQD
April 26, 2019/Digestive/News

6 Cleveland Clinic Presentations You’ll Want to Catch at DDW 2019

A preview of research findings that could impact your GI practice

GI CME
March 21, 2019/Cancer

Don’t Miss This Stellar CME Opportunity in IBD Management

More CME: GI endoscopy, medical/surgical options for Crohn’s disease, ulcerative colitis

18-DDI-2630-reguieroPtnt-650×450
February 22, 2019/Digestive/Q&A

“It Takes a Village” to Provide Exceptional Patient Care

Build the team and listen to its members, this gastroenterology leader advises

Gastroparesis Clinic-690×380

How We Improve Conditions for Complex Cases, from Gastroparesis to IBD

Innovative Cleveland Clinic programs reduce fragmentation of care

BackPage 3 of 5Next

Advertisement

Ad